title: Safety and efficacy of aneurysm treatment with WEB: results of the WEBCAST study.
abstract: OBJECT WEB is an innovative intrasaccular treatment for intracranial aneurysms. Preliminary series have shown good safety and efficacy. The WEB Clinical Assessment of Intrasaccular Aneurysm Therapy (WEBCAST) trial is a prospective European trial evaluating the safety and efficacy of WEB in wide-neck bifurcation aneurysms. METHODS Patients with wide-neck bifurcation aneurysms for which WEB treatment was indicated were included in this multicentergood clinical practices study. Clinical data including adverse events and clinical status at 1 and 6 months were collected and independently analyzed by a medical monitor. Six-month follow-up digital subtraction angiography was also performed and independently analyzed by a core laboratory. Success was defined at 6 months as complete occlusion or stable neck remnant, no worsening in angiographic appearance from postprocedure, and no retreatment performed or planned. RESULTS Ten European neurointerventional centers enrolled 51 patients with 51 aneurysms. Treatment with WEB was achieved in 48 of 51 aneurysms (94.1%). Adjunctive implants (coils/stents) were used in 4 of 48 aneurysms (8.3%). Thromboembolic events were observed in 9 of 51 patients (17.6%), resulting in a permanent deficit (modified Rankin Scale [mRS] Score 1) in 1 patient (2.0%). Intraoperative rupture was not observed. Morbidity (mRS score > 2) and mortality were 2.0% (1 of 51 patients, related to rupture status on entry to study) and 0.0% at 1 month, respectively. Success was achieved at 6 months in 85.4% of patients treated with WEB: 23 of 41 patients (56.1%) had complete occlusion, 12 of 41 (29.3%) had a neck remnant, and 6 of 41 (14.6%) had an aneurysm remnant. CONCLUSIONS The WEBCAST study showed good procedural and short-term safety of aneurysm treatment with WEB and good 6-month anatomical results.
authors.affiliation: Department of Neuroradiology, Hôpital Maison-Blanche, Université Reims-Champagne-Ardenne, Reims;
authors.forename: Laurent
authors.initials: L
authors.lastname: Pierot
authors.affiliation: Department of Neuroradiology, CHU Montpellier;
authors.forename: Vincent
authors.initials: V
authors.lastname: Costalat
authors.affiliation: Department of Neuroradiology, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy;
authors.forename: Jacques
authors.initials: J
authors.lastname: Moret
authors.affiliation: Department of Neuroradiology, National Institute of Neurosciences, Budapest, Hungary;
authors.forename: Istvan
authors.initials: I
authors.lastname: Szikora
authors.affiliation: Department of Neuroradiology, Helios General Hospital, Erfurt;
authors.forename: Joachim
authors.initials: J
authors.lastname: Klisch
authors.affiliation: Department of Neuroradiology CHU Tours;
authors.forename: Denis
authors.initials: D
authors.lastname: Herbreteau
authors.affiliation: Department of Neuroradiology, Rigshospitalet, Copenhagen, Denmark; and.
authors.forename: Markus
authors.initials: M
authors.lastname: Holtmannspötter
authors.affiliation: Department of Neuroradiology, Knappschaftskrankenhaus, Recklinghausen;
authors.forename: Werner
authors.initials: W
authors.lastname: Weber
authors.affiliation: Department of Neuroradiology CHU Toulouse, France;
authors.forename: Anne-Christine
authors.initials: AC
authors.lastname: Januel
authors.affiliation: Department of Neuroradiology Universitätsklinikum Köln, Cologne, Germany;
authors.forename: Thomas
authors.initials: T
authors.lastname: Liebig
authors.affiliation: Department of Neuroradiology, Helios General Hospital, Erfurt;
authors.forename: Vojtech
authors.initials: V
authors.lastname: Sychra
authors.affiliation: Department of Neuroradiology, Helios General Hospital, Erfurt;
authors.forename: Christoph
authors.initials: C
authors.lastname: Strasilla
authors.affiliation: Department of Neuroradiology CHU Toulouse, France;
authors.forename: Christophe
authors.initials: C
authors.lastname: Cognard
authors.affiliation: Department of Neuroradiology, CHU Montpellier;
authors.forename: Alain
authors.initials: A
authors.lastname: Bonafé
authors.affiliation: Oxford Neurovascular & Neuroradiology Research Unit, Oxford Radcliffe Hospital, Oxford, United Kingdom.
authors.forename: Andrew
authors.initials: A
authors.lastname: Molyneux
authors.affiliation: Oxford Neurovascular & Neuroradiology Research Unit, Oxford Radcliffe Hospital, Oxford, United Kingdom.
authors.forename: James V
authors.initials: JV
authors.lastname: Byrne
authors.affiliation: Department of Neuroradiology, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy;
authors.forename: Laurent
authors.initials: L
authors.lastname: Spelle
mesh_terms: D000328:Adult; D000368:Aged; D000497:Alloys; D015901:Angiography, Digital Subtraction; D002423:Cause of Death; D003131:Combined Modality Therapy; D015194:Diffusion Chambers, Culture; D004621:Embolization, Therapeutic / Q000295:instrumentation* / Q000379:methods*; D057510:Endovascular Procedures / Q000295:instrumentation* / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002532:Intracranial Aneurysm / Q000000981:diagnostic imaging / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D061214:Patient Safety; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011183:Postoperative Complications / Q000000981:diagnostic imaging / Q000401:mortality; D011446:Prospective Studies; D019736:Prostheses and Implants; D015607:Stents; D013923:Thromboembolism / Q000000981:diagnostic imaging / Q000401:mortality / Q000517:prevention & control; D016896:Treatment Outcome
chemical_list: D000497:Alloys; D010975:Platelet Aggregation Inhibitors; C013616:nitinol
keywords: ACoA = anterior communicating artery; BA = basilar artery; CCT = Cerecyte Coil Trial; DSA = digital subtraction angiography; ICA = internal carotid artery; ITT = intention to treat; MCA = middle cerebral artery; WEB; WEBCAST = WEB Clinical Assessment of Intrasaccular Aneurysm Therapy; endovascular treatment; flow-diverter device; intracranial aneurysms; mRS = modified Rankin Scale; vascular disorders